These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27171078)

  • 1. Identification of More Feasible MicroRNA-mRNA Interactions within Multiple Cancers Using Principal Component Analysis Based Unsupervised Feature Extraction.
    Taguchi YH
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27171078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
    Wilk G; Braun R
    Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease.
    Taguchi YH; Iwadate M; Umeyama H
    BMC Bioinformatics; 2015 Apr; 16():139. PubMed ID: 25925353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships.
    Hao JF; Ren KM; Bai JX; Wang SN; Shao B; Cao N; Li X
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C167-77. PubMed ID: 25450277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-mRNA network detects hub mRNAs and cancer specific miRNAs in lung cancer.
    Devaraj S; Natarajan J
    In Silico Biol; 2011-2012; 11(5-6):281-95. PubMed ID: 23202429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
    Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
    Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.
    Yang C; Sun C; Liang X; Xie S; Huang J; Li D
    Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
    Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
    Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer.
    Zhou XL; Wu JH; Wang XJ; Guo FJ
    Mol Med Rep; 2015 Jul; 12(1):885-94. PubMed ID: 25760063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
    Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
    Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA and miRNA analyses in cytologically positive endobronchial ultrasound-guided transbronchial needle aspiration: implications for molecular staging in lung cancer patients.
    Plönes T; Elze M; Kayser G; Pfeifer D; Burger M; Zissel G
    Cancer Cytopathol; 2014 Apr; 122(4):292-8. PubMed ID: 24574164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
    Ramesh V; Ganesan K
    Genes Cells; 2016 Sep; 21(9):949-65. PubMed ID: 27465470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RWRMDA: predicting novel human microRNA-disease associations.
    Chen X; Liu MX; Yan GY
    Mol Biosyst; 2012 Oct; 8(10):2792-8. PubMed ID: 22875290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.